Nomura Asset Management’s Corebridge Financial CRBG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
88,838
-44,170
-33% -$1.19M 0.01% 695
2026
Q1
$3.17M Buy
133,008
+10,539
+9% +$295K 0.01% 668
2025
Q4
$3.69M Buy
122,469
+16,000
+15% +$492K 0.01% 654
2025
Q3
$3.41M Sell
106,469
-56,900
-35% -$1.94M 0.01% 659
2025
Q2
$5.8M Buy
163,369
+76,889
+89% +$2.39M 0.02% 563
2025
Q1
$2.73M Hold
86,480
– – 0.01% 678
2024
Q4
$2.59M Hold
86,480
– – 0.01% 698
2024
Q3
$2.52M Buy
86,480
+11,000
+15% +$311K 0.01% 709
2024
Q2
$2.2M Hold
75,480
– – 0.01% 703
2024
Q1
$2.17M Buy
75,480
+73,580
+3,873% +$1.82M 0.01% 707
2023
Q4
$41.2K Hold
1,900
– – ﹤0.01% 1110
2023
Q3
$37.5K Hold
1,900
– – ﹤0.01% 1114
2023
Q2
$33.6K Hold
1,900
– – ﹤0.01% 1171
2023
Q1
$30.4K Buy
+1,900
New +$37.2K ﹤0.01% 1175

Other funds holding CRBG

Nomura Asset Management's CRBG Position: Q2 2026 in Review

Nomura Asset Management reduced its Corebridge Financial (CRBG) stake by 33% in Q2 2026, selling an estimated $1.19M and leaving 88,838 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #695.

Nomura Asset Management first reported a position in CRBG in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.8M in Q2 2025. 448 funds tracked by Wall St. Rank hold CRBG as of Q2 2026.

  • Nomura Asset Management held 88,838 shares of Corebridge Financial worth $2.54M as of Q2 2026.
  • Nomura Asset Management sold 44,170 Corebridge Financial shares in Q2 2026, an estimated $1.19M.
  • Corebridge Financial made up 0.01% of Nomura Asset Management's portfolio in Q2 2026, its #695 holding.
  • Nomura Asset Management first reported a position in Corebridge Financial in Q1 2023 and has held it in 14 quarters since.
  • Nomura Asset Management's Corebridge Financial position peaked at $5.8M in Q2 2025.
  • 448 funds tracked by Wall St. Rank held Corebridge Financial as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.